Brown University’s Royalty Pharma RPRX Stock Holding History

Brown University’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-331,759	Closed	-$13.3M	–	7
2022 Q3	$13.3M	Sell	331,759 -290,000	-47%	-$12.4M	5.41%	4
2022 Q2	$26.1M	Hold	621,759	–	–	7.77%	3
2022 Q1	$24.2M	Hold	621,759	–	–	5.93%	3
2021 Q4	$24.8M	Hold	621,759	–	–	6.04%	3
2021 Q3	$22.5M	Buy	621,759 +240,000	+63%	+$9.33M	3.05%	3
2021 Q2	$15.6M	Hold	381,759	–	–	2.59%	4
2021 Q1	$16.7M	Hold	381,759	–	–	11.44%	3
2020 Q4	$19.1M	Hold	381,759	–	–	13.82%	3
2020 Q3	$16.1M	Hold	381,759	–	–	11.43%	3
2020 Q2	$18.5M	Buy	+381,759	New	+$18.9M	13.65%	3

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown University's RPRX Position: Q4 2022 in Review

Brown University sold out of Royalty Pharma (RPRX) in Q4 2022, closing a stake of 331,759 shares — an estimated $13.3M sold.

Brown University first reported a position in RPRX in Q2 2020 and held it in 10 quarters. The position peaked at $26.1M in Q2 2022. 334 funds tracked by Wall St. Rank hold RPRX as of Q4 2022.

Brown University reported no remaining Royalty Pharma position as of Q4 2022 after selling out during the quarter.
Brown University sold 331,759 Royalty Pharma shares in Q4 2022, an estimated $13.3M.
Brown University first reported a position in Royalty Pharma in Q2 2020 and held it in 10 quarters.
Brown University's Royalty Pharma position peaked at $26.1M in Q2 2022.
334 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2022.

Based on Brown University's 13F filing for Q4 2022, filed 24 Jan 2023.